Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects
Shailendra KapoorMechanicsville, Richmond, VA, USAI read with great interest the article by Andukuri et al in a recent issue of your journal.1 The article makes compelling reading. Interestingly, research over the past few years has shown that in addition to its significant diabetic-modulating effec...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/473533d610504808a0eb52dd8801e5da |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:473533d610504808a0eb52dd8801e5da |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:473533d610504808a0eb52dd8801e5da2021-12-02T01:24:23ZPotent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects1178-7007https://doaj.org/article/473533d610504808a0eb52dd8801e5da2012-05-01T00:00:00Zhttp://www.dovepress.com/potent-antiatherosclerotic-effects-of-alogliptin-in-addition-to-its-po-a9887https://doaj.org/toc/1178-7007Shailendra KapoorMechanicsville, Richmond, VA, USAI read with great interest the article by Andukuri et al in a recent issue of your journal.1 The article makes compelling reading. Interestingly, research over the past few years has shown that in addition to its significant diabetic-modulating effects, alogliptin also exerts significant direct antiatherosclerotic effects.View original paper by Andukuri and colleaguesKapoor SDove Medical PressarticleSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol 2012, Iss default, Pp 121-123 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Specialties of internal medicine RC581-951 |
spellingShingle |
Specialties of internal medicine RC581-951 Kapoor S Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects |
description |
Shailendra KapoorMechanicsville, Richmond, VA, USAI read with great interest the article by Andukuri et al in a recent issue of your journal.1 The article makes compelling reading. Interestingly, research over the past few years has shown that in addition to its significant diabetic-modulating effects, alogliptin also exerts significant direct antiatherosclerotic effects.View original paper by Andukuri and colleagues |
format |
article |
author |
Kapoor S |
author_facet |
Kapoor S |
author_sort |
Kapoor S |
title |
Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects |
title_short |
Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects |
title_full |
Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects |
title_fullStr |
Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects |
title_full_unstemmed |
Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects |
title_sort |
potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects |
publisher |
Dove Medical Press |
publishDate |
2012 |
url |
https://doaj.org/article/473533d610504808a0eb52dd8801e5da |
work_keys_str_mv |
AT kapoors potentantiatheroscleroticeffectsofalogliptininadditiontoitspotentantidiabeticeffects |
_version_ |
1718403070367367168 |